We have studied the properties of N-7-4-nitrobenzo-2-oxa-1,3-diazole-w-aminohexanoic acid,-N-trimethylammonium)ethyl ester, a fluorescent analog of acetylcholine at the cellular level by using pharmacological and electrophysiological techniques and at tSe molecular level by measuring the kinetics of interaction with solubilized acetylcholine receptor and with acetylcholine esterase (EC 3.1.1.7). The fluorescent drug is a powerful agonist of acetylcholine at the neuromuscular junction and afso strongly desensitizes muscle fibers. Interaction with acetylcholine receptor is accompanied by large changes in the drug's fluorescence. From the kinetics of interaction studied by means of a stopped-flow fluorimeter with laser light source, we obtained a second-order forward rate constant in excess of 1 X 108 M-1 sec-t and an initial dissociation rate constant (kl) of 0.5 sec-1 for receptor from Electrophorus electricus. Interaction of this analog with acetylcholine esterase from E. electricus is accompanied by a transient decrease in fluorescence followed by an increase leading to a stable plateau value at a level near the original one. The initial decrease in fluorescence followed second-order kinetics with k2 of the order of 109 M-' sec-1. The slower consecutive reaction, which could be blocked by phosphorylation of the esteratic site, was of first order with k1 = 0.05 sec-1. Neuromuscular junctions can transmit nerve impulses at rates of 10-50 Hz (1); hence, the events associated with chemical excitation have to be terminated in a comparable time frame. The response of the endplate can be studied within the physiological time range of milliseconds by electrophysiological techniques, but ligand-binding studies using classical biochemical methods are generally too slow to provide data on the transient occupation of receptors. The need for a fluorescent cholinergic agonist to be applied in conjunction with rapid kinetic techniques has long been recognized (2, 3) . Earlier attempts to synthesize such ligands were only partly successful (4-9) in that these compounds were either antagonists or mixed effectors displaying some agonist activity together with properties of local anesthetics or noncompetitive blockers. Similarly, drugs of the phenanthridium (10) or 9-aminoacridine (11) type with their strong affinity for hydrophobic sites (12, 13) do not have the specificity required for an unambiguous active site probe. Finally, the intrinsic fluorescence of the receptor protein, although it is the least perturbing probe, is unusually weak. Besides its limited specificity (14), it is also difficult to separate from the high scattered light background of microheterogeneous samples and, in the case of membrane-bound receptor, from the fluorescence signal of other membrane proteins (15, 16) .
initial dissociation rate constant (kl) of 0.5 sec-1 for receptor from Electrophorus electricus. Interaction of this analog with acetylcholine esterase from E. electricus is accompanied by a transient decrease in fluorescence followed by an increase leading to a stable plateau value at a level near the original one. The initial decrease in fluorescence followed second-order kinetics with k2 of the order of 109 M-' sec-1. The slower consecutive reaction, which could be blocked by phosphorylation of the esteratic site, was of first order with k1 = 0.05 sec-1.
Neuromuscular junctions can transmit nerve impulses at rates of 10-50 Hz (1); hence, the events associated with chemical excitation have to be terminated in a comparable time frame. The response of the endplate can be studied within the physiological time range of milliseconds by electrophysiological techniques, but ligand-binding studies using classical biochemical methods are generally too slow to provide data on the transient occupation of receptors. The need for a fluorescent cholinergic agonist to be applied in conjunction with rapid kinetic techniques has long been recognized (2, 3) . Earlier attempts to synthesize such ligands were only partly successful (4) (5) (6) (7) (8) (9) in that these compounds were either antagonists or mixed effectors displaying some agonist activity together with properties of local anesthetics or noncompetitive blockers. Similarly, drugs of the phenanthridium (10) or 9-aminoacridine (11) type with their strong affinity for hydrophobic sites (12, 13) do not have the specificity required for an unambiguous active site probe. Finally, the intrinsic fluorescence of the receptor protein, although it is the least perturbing probe, is unusually weak. Besides its limited specificity (14) , it is also difficult to separate from the high scattered light background of microheterogeneous samples and, in the case of membrane-bound receptor, from the fluorescence signal of other membrane proteins (15, 16) .
In this paper we introduce one example of a series of fluorescent derivatives of acetylcholine, N-7-(4-nitrobenzo-2-oxa-1,3-diazole)-w-aminohexanoic acid f3-(N-trimethylammonium)ethyl ester (NBD-5-acylcholine) that acts as agonist of acetylcholine at the neuromuscular junction and, at the same time, is a potent inhibitor of acetylcholine esterase (EC 3.1.1.7). Its interaction with solubilized or membrane-bound receptor from Electrophorus electricus, Torpedo californica, and T. marmorata and choline ester hydrolases is accompanied by large changes in fluorescence. It can therefore serve as an excellent marker molecule in the study of the molecular events during chemical excitation of cholivergic systems.
MATERIALS AND METHODS
Synthesis of NBD-n-Acylcholines. A detailed account of the synthesis and chemical characterization of the N-7-(4-nitrobenzo-2-oxa-1,3-diazole)-w-amino-n-alkanoic acid f-(N-trimethylammonium)ethyl esters will be published elsewhere. In short, previously prepared NBD-w-amino-alkanoic acid chloride was treated with 2-dimethylaminoethanol, and the resulting product, after thorough purification, was quaternized by using methyl iodide. The reaction product was dissolved in water and further purified by means of an anion exchange column. In the same step, Cl-was introduced as counter ion. The NBD-n-acylcholines were identified by elementary analysis, by NMR, infrared, and UV spectroscopy, and by their crystalline picrates. By the same procedure using (17) ; the inward voltage clamp current was recorded. Further experimental details are given in ref. 18 . In some experiments, the muscle preparations were pretreated with methylsulfonyl fluoride, a powerful acetylcholine esterase blocker. Analysis of "membrane noise" data is described elsewhere (19, 20 through individual channels were performed according to Neher and colleagues (21, 22) . Acetylcholine esterase from E. electricus was obtained from Boehringer Mannheim. The preparation and characterization of the acetylcholine receptor from the electric eel have been described (9, 23) . A similar procedure was applied to purify receptor protein from T. californica and T. marmorata (prepared by R. Ruchel of our group). Membrane fragments of Torpedo electroplax cells were prepared by a method involving repetitive centrifugations (prepared by A. Kipps of our group). Fluorescence spectra and equilibrium binding studies were performed by using an SLM 8000 photon-counting spectrofluorimeter equipped with a Hewlett-Packard 9815A calculator and 9862A plotter. All receptor concentrations given in this paper are in terms of NBD-5-acylcholine binding sites as determined by fluorescence equilibrium titrations. Kinetic experiments with acetylcholine esterase were performed at pH 6.8 (with the buffer used for dissolving NBD-5-acylcholine) and at pH 7.2 (with 0.05 M phosphate buffer). Spontaneous and esterase-catalyzed hydrolysis of NBD-5-acylcholine was measured by comparing the fluorescence intensities or the radioactivity of the drug and its hydrolysis products after separation by thin-layer chromatography. After various times of incubation, NBD-5-acylcholine was separated from the acid by using silica gel type "60 PF" (Merck, Darmstadt, West Germany) with methanol/ethyl acetate, 1:1 (vol/ vol), as solvent.
[3H]NBD-5-acylcholine was separated from [3H]choline on silica gel type "60 PF silanisiert" (Merck, Darmstadt, West Germany) with methanol/ethyl acetate, 8:2 (vol/vol). The spots were extracted with water and assayed for radioactivity in a liquid scintillation counter. NMR spectra were measured with a Varian EM 390 NMR spectrometer with tetramethylsilane as internal standard.
RESULTS
Structure and Spectroscopic Properties of NBD-5-Acylcholine. The structure of NBD-5-acylcholine and its NMR spectrum are shown in Fig. 1 . The acetylcholine analog had the characteristic UV absorption and fluorescence properties of 7-amino derivatives of 4-nitrobenzo-2-oxa-1,3-diazole with the main absorption peaks at 227, 349, and 486 nm and the emission maximum at 525 nm (24, 25) . The molar extinction coefficient at 486 nm was 27,000.
Pharmacological and Electrophysiological Characterization. A first indication of the agonist properties of the drug was obtained by measuring the isometric contractions of rat diaphragm induced by stepwise increments in drug concentration. At low drug concentrations (0.1 ,uM) NBD-5-acylcholine was at least 100-fold more potent than acetylcholine when assayed as an agonist under these conditions, and the effect of the analog was completely blocked by d-tubocurarine (0.1 mM) or cobra a-neurotoxin (0.1 ,uM). With the frog cutaneous pectoris muscle, a strong depolarizing action of the drug was observed that was completely prevented by pretreatment with blocking agents.
To substantiate these initial findings a more detailed and time-resolved electrophysiological characterization was undertaken in the laboratory of B. Sakmann and E. Neher (MaxPlanck-Institut fuir Biophysikalische Chemie) in G6ttingen. The ,uM carbamylcholine in its response (Fig. 2 left) . However, although repeated applications of carbamylcholine produced the same endplate current, even low concentrations of the fluorescent drug caused a rapid decrease in signal amplitude and a lower response to subsequently added carbamylcholine. This desensitizing action of the drug was increasingly pronounced as its concentration was increased and was fully reversible within 30-60 min after the bathing fluid was changed.
To determine the mean open time of the ion channel activated by NBD-5-acylcholine, voltage clamp currents through individual channels of frog cutaneous pectoris muscle fibers were recorded during iontophoretic application of constant doses of the drug and the drug-induced current fluctuations were analyzed. The open time of a single channel derived from the halfpower frequencies of "membrane noise" power spectra (Fig. 2 right) concentration of Tween 80, the fluorescence of NBD-5-acylcholine is strongly quenched upon binding to solubilized eel receptor. Using analysis of the time course of these changes in fluorescence, we have begun a study of the reaction by rapid mixing techniques. To accommodate the millisecond time resolution of stopped-flow systems, the concentration of reactants applied was reduced to a level at which the rate of association of drug and receptor was sufficiently slow to be recorded. Fluorescence signals of sufficient amplitude were obtained by using, as light source, a 4-W argon laser tuned to 488 nm. As examples we show in Fig. 3 the results of an association and a dissociation experiment of NBD-5-acylcholine with purified receptor from E. electricus.
Association of NBD-5-acylcholine and eel receptor (Fig. 3  upper) did not conform to the rate law of a reversible secondorder reaction nor to a first-order reaction. Instead, the kinetics Guggenheim (26) and were then subjected to a linear regression analysis. First-order rate constant k = 0.5 sec-1. seemed to be composed of two or more consecutive reactions, the first one being of second order. From the half-times of the total reactions we obtained second-order forward rate constants larger than 1 X 108 M-1 sec-1 in all our experiments. Similar rate constants were obtained by fitting the initial part of the kinetic curves with the rate law of a reversible second-order reaction (Fig. 3 upper) .
The dissociation rate of receptor-drug complexes was determined by rapid mixing of the preformed complex with an equal volume of buffer containing a large excess of a nonfluorescent ligand such as decamethonium or tubocurarine. Data were analyzed by plotting the logarithm of fluorescence versus time according to Guggenheim (26) . The dissociation of Electrophorus receptor-NBD-5-acylcholine complexes as determined by the increase in fluorescence upon mixing of preformed complex and decamethonium (Fig. 3 lower) was not a single first-order reaction. From the initial linear part of the plots we obtained the rate constant k1 = 0.5 sec-1. From the rate constants of dissociation and association, an equilibrium disProc. Natl. Acad. Sci. USA 76 (1979) 1067 sociation constant Kd = 3 X 10-9 M was calculated, which is in agreement with our equilibrium studies.
Similar experiments were performed with solubilized receptor from T. californica and T. marmorata and with membrane preparations of these sources. Binding of NBD-5-acylcholine to purified Torpedo receptor was accompanied by an increase in fluorescence followed by a decrease, and dissociation of drug-receptor complexes was accompanied by a change in fluorescence to the original fluorescence level of the free drug. Because direction and size of the fluorescence changes upon binding of NBD-5-acylcholine was different for receptor from eel and ray, it follows that the microenvironment of the drug's fluorescent moiety must be different in the particular complexes formed. The kinetics of association with NBD-5-acylcholine, however, were similarly fast for receptor of both species.
With receptor-rich membrane fragments from T. marmorata the fluorescence of the drug was quenched upon binding. Under experimental conditions similar to those shown in Fig.  3 upper we found forward rate constants clearly in excess of 108 M-1 sec-'. However, because of their tnicroheterogeneity, the membrane preparations introduced more background noise into the oscilloscope traces of the reaction and significantly more experiments are needed for quantitative substantiation of these initial findings.
Interaction of NBD-5-Acylcholine with Acetylcholine Esterase. Steady-state kinetic studies of acetylcholine hydrolysis by acetylcholine esterase from E. electricus showed that NBD-5-acylcholine was a competitive inhibitor with Ki = 5 X 10-8 M (unpublished data). Acetylcholine was hydrolyzed by the esterase several thousand times more rapidly than was the analog as shown by incubating radioactively labeled NBD-5-acylcholine with esterase for various periods of time followed by separation of original drug and hydrolysis products. Although we did not observe large fluorescence changes in equilibrium binding studies with drug and esterase, we tested the system in the stopped-flow fluorimeter. Rapid mixing of the two reactants resulted in a strong decrease in fluorescence intensity followed by an increase to a level of fluorescence approaching that of the free drug (Fig. 4) . Because neither N-NBD-ethylamine nor NBD-6-aminohexanoic acid methyl ester produced any fluorescence change upon mixing with the enzyme, the effect with NBD-5-acylcholine must be the result of the interaction of the cholinergic site of the drug with the enzyme. Blocking the enzyme's esteratic site by phosphorylation with diisopropylphosphorofluoridate did not affect the initial fast decrease of fluorescence upon addition of NBD-5-acylcholine but completely abolished the consecutive slow increase in fluorescence. At the concentrations of reactants applied in the stopped-flow experiments, NBD-5-acylcholine is hydrolyzed by esterase at a rate comparable to that of this slow fluorescence increase, which might therefore be due to the formation of the unbound hydrolysis products.
Initial binding of NBD-5-acylcholine to the esterase was very rapid (Fig. 4 upper) . In the presence of a large excess of drug (45.7 nM) over esterase (0.508 nM), the pseudo-first-order rate constant obtained from the slope of Fig. 4 upper inset was ki = 44 sec-1. Dividing kI by the concentration of the ligand gives the second-order rate constant k2 = 1 X 109 M-1 sec1-. Similar experiments at various ligand concentrations yielded secondorder rate constants of the same order of magnitude. The consecutive increase in fluorescence was of first order with k1 = 0.05 sec-1.
DISCUSSION
The response of receptors to transmitter binding is central to their biological function, and elucidation of the sequence of molecular events that follow the presynaptic release of transmitter will ultimately require a time-resolved analysis of all reactions involved. In the case of the rapidly responding cholinergic system, binding studies using radioactively labeled ligands do not provide the necessary time resolution and hence other procedures, such as rapid kinetic techniques using spectroscopic markers, are required. Of the many compounds developed for this purpose (4-11), NBD-5-acylcholine is the only one whose properties appear to be advantageous for the following reasons.
(i) The spectral properties of NBD-5-acylcholine are favorable: the quantum yield of fluorescence in aqueous media is high, and both the excitation and emission maxima (486 nm and 525 nms respectively) are remote from the UV absorption range of proteins, other macromolecules, and membrane components. Furthermore, the proximity of the fluorescence excitation maximum to the main output line of argon lasers and the resistance of NBD-5-acylcholine to photobleaching make it an ideal probe for use with high-intensity light sources, thereby extending the range both of applicable concentrations and of detectable spectral responses.
(ii) Being hydrolyzed by acetylcholine esterase so much more slowly than acetylcholine (several thousand-fold difference), NBD-5-acylcholine does not undergo enzymatic hydrolysis within the time scale of the physiological responses that it can be used to analyze.
(iii) NBD-5-Acylcholine is an agonist at the neuromuscular junction. Its potency in depolarizing postsynaptic membranes, in stimulating muscle contraction, and in producing desensitization exceeds that of the natural transmitter acetylcholine. Hence, it can be used to probe all of the properties known to be associated with the agonist action of acetylcholine. Moreover, the pharmacological properties of the analog appear so far to be quite simple, at least at the level of neuromuscular preparations, because the effects of NBD-5-acylcholine are uncomplicated by local anesthetic action or by perturbation of sodium channels. Indeed, the effects of analog and natural transmitter were additive at the neuromuscular junction.
From the results obtained to date with isolated E. electricus receptor, the rate of association with NBD-5-acylcholine is rapid (k2 > 1 X 108 M-1 sec'); however, due to the complexity of this reaction (Fig. 3 upper) and documented in preliminary data from experiments with Torpedo receptor and membrane fragments, this value may only be a lower limit. Our values for the association are already significantly larger than those deduced indirectly by Neumann and Chang (27) from the rates of Ca2+ release following receptor exposure to acetylcholine at pH 8.5 .
It is a puzzling observation that the mean open time of the receptor-controlled channel (2-3 msec) and the half-time of dissociation of NBD-5-acylcholine-receptor complexes (Q2 sec) differ by orders of magnitude. This may imply that the receptor triggers only the opening of the channel and that its closing is an independent process.
Like acetylcholine itself, NBD-5-acylcholine interacts with acetylcholine esterase, although the analog is hydrolyzed only very slowly. The rate of association was rapid and close to diffusion controlled, as previously inferred for acetylcholine (28) .
In summary, NBD-5-acylcholine is a fluorescent analog of acetylcholine that behaves unambiguously as an agonist at and molecular correlates for well-established electrophysiological observations.
